Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15. No abstract available. Erratum in: Circulation. 2012 Jun 5;125(22):e1002.

2.

Catheter ablation for atrial fibrillation.

Wazni O, Wilkoff B, Saliba W.

N Engl J Med. 2011 Dec 15;365(24):2296-304. doi: 10.1056/NEJMct1109977. Review. No abstract available.

PMID:
22168644
3.

The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades.

Weimar T, Schena S, Bailey MS, Maniar HS, Schuessler RB, Cox JL, Damiano RJ Jr.

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):8-14. doi: 10.1161/CIRCEP.111.963819. Epub 2011 Nov 17.

4.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

5.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

6.

Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience.

Lam YY, Yip GW, Yu CM, Chan WW, Cheng BC, Yan BP, Clugston R, Yong G, Gattorna T, Paul V.

Catheter Cardiovasc Interv. 2012 Apr 1;79(5):794-800. doi: 10.1002/ccd.23136. Epub 2011 Nov 30.

PMID:
21542102
7.

2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC Jr, Priori SG, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG, Tarkington LG, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force.

Circulation. 2011 Mar 15;123(10):e269-367. doi: 10.1161/CIR.0b013e318214876d. Epub 2011 Mar 7. No abstract available.

8.
9.

Feasibility of closed-chest ligation of the left atrial appendage in humans.

Bartus K, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Yakubov SJ, Lee RJ.

Heart Rhythm. 2011 Feb;8(2):188-93. doi: 10.1016/j.hrthm.2010.10.040. Epub 2010 Nov 2.

PMID:
21050893
10.

Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience.

Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minguez JR, Meerkin D, Valdés M, Ormerod O, Leithäuser B.

Catheter Cardiovasc Interv. 2011 Apr 1;77(5):700-6. doi: 10.1002/ccd.22764. Epub 2011 Mar 8. Erratum in: Catheter Cardiovasc Interv. 2014 Nov 15;84(6):1028. Lopez-Minquez, Jose Ramon [corrected to Lopez-Minguez, Jose Ramon].

PMID:
20824765
11.

Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation.

Beinart R, Heist EK, Newell JB, Holmvang G, Ruskin JN, Mansour M.

J Cardiovasc Electrophysiol. 2011 Jan;22(1):10-5. doi: 10.1111/j.1540-8167.2010.01854.x.

PMID:
20662984
12.

Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model.

Lee RJ, Bartus K, Yakubov SJ.

Circ Cardiovasc Interv. 2010 Jun 1;3(3):224-9. doi: 10.1161/CIRCINTERVENTIONS.109.914978. Epub 2010 May 18.

13.

Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?

Dawson AG, Asopa S, Dunning J.

Interact Cardiovasc Thorac Surg. 2010 Feb;10(2):306-11. doi: 10.1510/icvts.2009.227991. Epub 2009 Nov 26. Review.

PMID:
19942634
14.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ.

Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.

PMID:
19762550
15.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

16.

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators.

Lancet. 2009 Aug 15;374(9689):534-42. doi: 10.1016/S0140-6736(09)61343-X. Erratum in: Lancet. 2009 Nov 7;374(9701):1596.

PMID:
19683639
17.

Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M.

JACC Cardiovasc Interv. 2009 Jul;2(7):594-600. doi: 10.1016/j.jcin.2009.05.005.

18.

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

Watson T, Shantsila E, Lip GY.

Lancet. 2009 Jan 10;373(9658):155-66. doi: 10.1016/S0140-6736(09)60040-4. Review.

PMID:
19135613
19.

Endothelial dysfunction and pathophysiological correlates in atrial fibrillation.

Guazzi M, Arena R.

Heart. 2009 Feb;95(2):102-6. doi: 10.1136/hrt.2007.135277. Review.

PMID:
19109515
20.

Epidemiology and outcomes in patients with atrial fibrillation in the United States.

Walker AM, Bennett D.

Heart Rhythm. 2008 Oct;5(10):1365-72. doi: 10.1016/j.hrthm.2008.07.014. Epub 2008 Jul 17.

PMID:
18929320

Supplemental Content

Support Center